prikaz prve stranice dokumenta Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa
  Download
PDF 943.27 KB
master's thesis
Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa
Rijeka: University of Rijeka, Faculty of Medicine, 2022. urn:nbn:hr:184:397453
Brčić, Luka
University of Rijeka
Faculty of Medicine
Department of Urology

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Brčić, L. (2022). Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa (Master's thesis). Rijeka: University of Rijeka, Faculty of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:397453

Brčić, Luka. "Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa." Master's thesis, University of Rijeka, Faculty of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:184:397453

Brčić, Luka. "Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa." Master's thesis, University of Rijeka, Faculty of Medicine, 2022. https://urn.nsk.hr/urn:nbn:hr:184:397453

Brčić, L. (2022). 'Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa', Master's thesis, University of Rijeka, Faculty of Medicine, accessed 13 May 2024, https://urn.nsk.hr/urn:nbn:hr:184:397453

Brčić L. Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa [Master's thesis]. Rijeka: University of Rijeka, Faculty of Medicine; 2022 [cited 2024 May 13] Available at: https://urn.nsk.hr/urn:nbn:hr:184:397453

L. Brčić, "Uloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa", Master's thesis, University of Rijeka, Faculty of Medicine, Rijeka, 2022. Available at: https://urn.nsk.hr/urn:nbn:hr:184:397453

Metadata
TitleUloga tumorskih markera u dijagnostici, liječenju i praćenju bolesnika s tumorom testisa
Title (english)The role of tumor markers in the diagnosis, treatment and follow up of patients with testicles tumor
AuthorLuka Brčić
MentorStanislav Sotošek (mentor)
Committee memberDean Markić (predsjednik povjerenstva)
Committee memberRomano Oguić (član povjerenstva)
Committee memberJosip Španjol (član povjerenstva)
GranterUniversity of Rijeka
Faculty of Medicine
(Department of Urology)
Rijeka
Defense date and country2022-07-15, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Urology
Abstract
Tumori testisa novotvorine su koje se dijele na benigne i maligne, s vrhuncem pojavljivanja u mlađoj životnoj dobi. Etiologija tumora testisa nije u potpunosti dokazana, iako je dosad utvrđeno nekoliko čimbenika rizika za nastanak ovih tumora. Prezentirajući se najčešće kao bezbolna masa u skrotumu, tumori testisa dijagnosticiraju se na temelju anamneze i fizikalnog pregleda nadopunjenog sa slikovnim dijagnostičkim metodama te mjerenjem koncentracije tumorskih markera u serumu. Osnova liječenja je kirurško odstranjenje testisa (orhidektomija) uz patohistološku analizu tumora te po potrebi radioterapija i kemoterapija. Nakon provedenog liječenja svakog je bolesnika potrebno pratiti minimalno 5 godina i kontinuirano mjeriti razine tumorskih markera u serumu, a po potrebi koristiti i slikovne dijagnostičke metode kako bi se na vrijeme otkrila i dalje postojeća bolest ili recidiv bolesti.
Abstract (english)
Testicular tumors are neoplasms that are divided into benign and malignant, with a peak incidence at a younger age. The etiology of testicular tumors has not been fully proven, but several risk factors for the development of these tumors have been identified. Most oftenly presented as a painless swelling in the scrotum, testicular tumors are diagnosed based on anamnesis and physical examination supplemented with imaging diagnostic methods and tumor marker levels in the serum. Basic treatment is surgical removal of the testicles (orchiectomy) with pathohistological analysis of the tumor and, if necessary, radiotherapy and chemotherapy. After treatment, each patient should be monitored for a minimum of 5 years with continuous measurement of serum tumor marker levels, and if necessary, use diagnostic diagnostic methods to detect residual disease or disease recurrence.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:184:397453
Study programmeTitle: Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica medicine (doktor/doktorica medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-06-27 15:00:14